HEALTH MANAGEMENT DEVICES AND METHODS

• US 20080319294A1
• Filed: 06/20/2008
• Published: 12/25/2008
• Est. Priority Date: 06/21/2007
• Status: Abandoned Application

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Taub, Marc B.
• Application Number:
  US12/143,725
• Publication Number:
  US 20080319294A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 10/0012 Ovulation-period determination for animals A61D17/002
• CPC Class Codes: A61B 2560/0223 of calibration, e.g. protocols for calibrating sensors
• CPC Class Codes: A61B 2560/045 with a separable interface unit, e.g. for communication
• CPC Class Codes: A61B 2560/0456 Apparatus provided with a docking unit
• CPC Class Codes: A61B 2560/0475 Special features of memory means, e.g. removable memory cards
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/002 Monitoring the patient using a local or closed circuit, e.g. in a room or building A61B5/0017 takes precedence
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/0024 for multiple sensor units attached to the patient, e.g. using a body or personal area network
• CPC Class Codes: A61B 5/0205 Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
• CPC Class Codes: A61B 5/02411 of foetuses
• CPC Class Codes: A61B 5/1118 Determining activity level
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/4356 Assessing uterine contractions A61B5/033 takes precedence
• CPC Class Codes: A61B 5/4836 Diagnosis combined with treatment in closed-loop systems or methods A61B5/0036 takes precedence
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/4848 Monitoring or testing the effects of treatment, e.g. of medication
• CPC Class Codes: A61B 5/486 : Bio-feedback A61B5/375 takes precedence
• CPC Class Codes: A61B 5/4866 : Evaluating metabolism A61B5/083 takes precedence
• CPC Class Codes: A61B 5/742 : using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61B 5/7465 : Arrangements for interactive communication between patient and care services, e.g. by using a telephone network telemetry of measured physiological signal A61B5/0002

Abstract

Methods, devices and systems to detect analyte level in a patient with gestational diabetes and/or provide related therapy management are provided.

Claims

1. A method, comprising:

monitoring an analyte level of a subject for gestational diabetic related condition over a predetermined time period;

storing a plurality of data associated with the monitored analyte level over the predetermined time period, the plurality of data having one or more parameters associated with the monitored analyte level; and

processing the stored plurality of data to determine, at least in part, one or more therapy regimen associated with the treatment of gestational diabetes.

2. The method of claim 1 generating one or more output based on the processed stored plurality of data or the therapy regimen.

3. The method of claim 2 wherein the one or more output includes one or more visual output or audible output.

4. The method of claim 2 including providing the generated output to the subject.

5. The method of claim 4 wherein providing the generated output includes displaying the generated output to the subject.

6. The method of claim 1 wherein the one or more parameters includes one or more of the monitored analyte levels, fetal heart rate data, uterine contraction information, diet information, physical activity information, prenatal care information, and medication information.

7. The method of claim 1 wherein the determined one or more therapy regimen includes a recommendation for modification to the diet of the subject, modification to the physical activity of the subject, or modification to the medication dosage information of the subject.

8. The method of claim 1 wherein the determined therapy regimen includes modification to one or more of a modification to a basal rate profile for insulin delivery to the subject.

9. The method of claim 1 wherein the analyte is glucose.

10. A method, comprising:

collecting analyte level information over a predetermined time period when one or more condition associated with gestational diabetes is detected; and

executing one or more computer program to process the collected analyte level information, wherein executing the one or more computer program includes;

selecting a predetermined function associated with the detected gestational diabetes;

retrieving one or more parameters associated with the collected analyte level information or the monitored gestational diabetes condition;

performing data analysis based on the retrieved one or more parameters and the collected analyte level information to generate one or more therapy management information associated with the monitored one or more condition associated with gestational diabetes.

11. The method of claim 10 wherein the one or more computer program is executed on a healthcare provider computer terminal, or a patient computer terminal or a remote terminal.

12. The method of claim 10 including transmitting the collected analyte level information to a remote location.

13. The method of claim 12 wherein the analyte level information is received over the internet.

14. The method of claim 13 wherein the analyte level information is encrypted when received.

15. The method of claim 14 including decrypting the encrypted analyte information.

16. The method of claim 10 including storing the generated one or more therapy management information.

17. A system for monitoring glucose level of a patient with gestational diabetes, comprising:

an analyte sensor to detect the analyte level of a patient with gestational diabetes over a predetermined time period;

a data processing unit coupled to the analyte sensor, the data processing unit including a processor to process a plurality of signals associated with the detected analyte level; and

a communication unit coupled to the data processing unit for communicating the plurality of signals associated with the detected analyte level of the patient to a remote location to determine, at least in part, one or more therapy regimen associated with the treatment of gestational diabetes.

18. The system of claim 17 wherein the communication from the communication unit is encrypted.

19. The system of claim 17 wherein the remote location includes a computer terminal in communication with the communication unit.

20. The system of claim 19 wherein the computer terminal is configured to communicate with the communication unit over a wired or a wireless connection or both.

21. The system of claim 17 wherein the remote location includes an output unit configured to output the one or more determined therapy regimen associated with the treatment of gestational diabetes.